Herbal therapy "PC-SPES" for Japanese patients with hormone-refractory prostate cancer

Nishinihon Journal of Urology

Volumn 65, Issue 7, 2003, Pages 460-465

  Urakami, Shinji ^a   Arichi, Naoko ^a   Takeda, Masaki ^a   Morita, Yuji ^a   Kikuno, Nobuyuki ^a   Yoshino, Tateki ^a   Imai, Shin ^a   Honda, Satoshi ^a   Yoneda, Tatsuaki ^a   Kishi, Hirofumi ^a   Shigeno, Kazushi ^a   Shiina, Hiroaki ^a   Igawa, Mikio ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Hormone refractory prostate cancer; PC SPES

Indexed keywords

CARBOPLATIN; ESTRAMUSTINE; PC SPES; TAXANE DERIVATIVE;

AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CASE REPORT; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; ESTROGEN ACTIVITY; HERBAL MEDICINE; HUMAN; MALE; PROSTATE CANCER;

EID: 0042155818     PISSN: 00290726     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Richardson, M. A. et al.: Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J. Clin. Oncol. 18: 2505-2514, 2000.
2. DiPaola, R. S. et al.: Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N. Engl. J. Med. 339: 785-791, 1998.
3. Pandha, H. S. and Kirby, R. S.: PC-SPES: phytotherapy for prostate cancer. Lancet 359: 2213-2215, 2002.
4. Marks, L. S. et al.: PC-SPES: herbal formulation for prostate cancer*. Urology 60: 369-377, 2002.
5. Hsieh, T. et al.: Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES. Biochem. Mol. Biol. Int. 42: 535-544, 1997.
6. Rafi, M. M. et al.: Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res. 20: 2653-2658, 2000.
7. Chenn, S.: In vitro mechanism of PC SPES. Urology 58: 28-35; Discussion 38, 2001.
8. Pirani, J. F.: The effects of phytotherapeutic agents on prostate cancer: an overview of recent clinical trials of PC SPES. Urology 58: 36-38, 2001.
9. Hsieh, T. C. et al.: Induction of apoptosis and down-regulation of bcl-6 in mutu I cells treated with ethanolic extracts of the Chinese herbal supplement PC-SPES. Int. J. Oncol. 13: 1199-1202, 1998.
10. Davis, N. B. et al.: Does PC-SPEs interact with warfarin? J. Urol. 167: 1793, 2002.
11. Weinrobe, M. C. and Montgomery, B.: Acquired bleeding diathesis in a patient taking PC-SPES. N. Engl. J. Med. 345: 1213-1214, 2001.
12. Small, E. J. et al.: Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J. Clin. Oncol. 18: 3595-3603, 2000.
13. de la Taille, A. et al.: Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. J. Urol. 164: 1229-1234, 2000.
14. Pfeifer, B. L. et al.: PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer. Br. J. Urol. 85: 481-485, 2000.
15. Oh, W. K. et al.: Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer. Urology 57: 122-126, 2001.
16. Small, E. J. and Harris, K. A.: Secondary hormonal manipulation of prostate cancer. Semin. Urol. Oncol. 20: 24-30, 2002.
17. Oh, W. K.: Secondary hormonal therapies in the treatment of prostate cancer. Urology 60: 87-92; Discussion 93, 2002.
18. Sovak, M. et al.: Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J. Natl. Cancer Inst. 94: 1275-1281, 2002.
19. Zhai, L. et al.: The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria. Antimicrob. Agents Chemother. 39: 2742-2748, 1995.
20. Wang, S. Y. et al.: The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer. 70: 699-705, 1997.
21. Smith, D. C. et al.: A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer. Urology 52: 257-260, 1998.